Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD studyNina Friis‐Møller, Jens Lundgren, S Mateu et al.|AIDS|2003Cited by 987
Lipid Profiles in HIV‐Infected Patients Receiving Combination Antiretroviral Therapy: Are Different Antiretroviral Drugs Associated with Different Lipid Profiles?Éric Fontas, Frank van Leth, Caroline Sabin et al.|The Journal of Infectious Diseases|2004Cited by 336
Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.Nina Friis‐Møller, Jens Lundgren, Rainer Weber et al.|PubMed|2003Cited by 327
The use of the Framingham equation to predict myocardial infarctions in HIV‐infected patients: comparison with observed events in the D:A:D StudyMatthew Law, Nina Friis‐Møller, WM El‐Sadr et al.|HIV Medicine|2006Cited by 298
Modelling the 3‐year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti‐HIV Drugs (DAD) studyMatthew Law, Nina Friis‐Møller, Rainer Weber et al.|HIV Medicine|2003Cited by 250